Pharmacodynamic Profiling of Amoxicillin: Targeting Multidrug-Resistant Gram-Positive Pathogens Staphylococcus aureus
Syed Al Jawad Sayem1, Ga-Yeong Lee1, Muhammad Aleem Abbas1
1Laboratory of Veterinary Pharmacokinetics and Pharmacodynamics, Institute for Veterinary Biomedical Science, College of Veterinary Medicine, Kyungpook National University, Daegu 41566, Republic of Korea.
Abstract:
The rising threat of antimicrobial resistance (AMR) is a global concern in both human and veterinary medicine, with multidrug-resistant (MDR) pathogens such as Staphylococcus aureus and Staphylococcus pseudintermedius presenting significant challenges. Background/Objectives: This study evaluates the effectiveness of amoxicillin against these MDR pathogens in canine isolates using pharmacokinetic and pharmacodynamic parameters. Methods: Minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and mutation prevention concentration (MPC) were assessed. Additionally, time-kill assays and post-antibiotic effect (PAE) assessments were performed. Epidemiological cutoff (ECOFF) values were established for both species to guide therapy. Results: S. aureus had a higher resistance rate (35.89%) than S. pseudintermedius (15.27%), with MIC50 values of 0.50 μg/mL and 0.25 μg/mL, respectively. The MPC analysis revealed that S. pseudintermedius required higher antibiotic concentrations (16.11 μg/mL) to prevent mutations compared to S. aureus (2.20 μg/mL). Time-kill assays indicated that higher amoxicillin dosages caused faster bacterial reduction. The PAE analysis showed extended post-treatment bacterial suppression at elevated doses, particularly against S. aureus. Conclusions: Species-specific amoxicillin dosing strategies are necessary due to differing resistance and susceptibility profiles between S. aureus and S. pseudintermedius. High-dose amoxicillin therapy is recommended to achieve optimal therapeutic outcomes for resistant SA, while slightly adjusted dosing can manage S. pseudintermedius infections. These findings provide essential insights for veterinary antimicrobial stewardship, underscoring the need for tailored therapeutic approaches to minimize AMR development while ensuring effective infection control.
Insights
Antimicrobial resistance (AMR) necessitates tailored amoxicillin dosing for canine Staphylococcus infections. High-dose amoxicillin is effective against resistant Staphylococcus aureus, while Staphylococcus pseudintermedius requires adjusted dosing for optimal outcomes.
Area of Science:
- Veterinary Pharmacology
- Antimicrobial Resistance Research
- Canine Infectious Diseases
Background:
- Multidrug-resistant (MDR) pathogens like Staphylococcus aureus and Staphylococcus pseudintermedius pose significant threats in veterinary medicine.
- Antimicrobial resistance (AMR) is a growing global concern, impacting both human and animal health.
- Effective treatment strategies are crucial to combat MDR infections in companion animals.
Purpose of the Study:
- To evaluate amoxicillin's efficacy against MDR Staphylococcus aureus and Staphylococcus pseudintermedius in canine isolates.
- To determine optimal pharmacokinetic/pharmacodynamic (PK/PD) parameters for amoxicillin therapy in dogs.
- To establish species-specific dosing recommendations to mitigate AMR development.
Main Methods:
- Determination of Minimum Inhibitory Concentration (MIC), Minimum Bactericidal Concentration (MBC), and Mutation Prevention Concentration (MPC).
- Performance of time-kill assays and post-antibiotic effect (PAE) assessments.
- Establishment of Epidemiological Cutoff (ECOFF) values for guiding therapeutic decisions.
Main Results:
- Staphylococcus aureus exhibited a higher resistance rate (35.89%) than Staphylococcus pseudintermedius (15.27%).
- Higher amoxicillin concentrations were needed to prevent mutations in Staphylococcus pseudintermedius (16.11 μg/mL) compared to Staphylococcus aureus (2.20 μg/mL).
- Time-kill assays and PAE analyses demonstrated that elevated amoxicillin doses led to faster bacterial reduction and prolonged suppression, especially against Staphylococcus aureus.
Conclusions:
- Species-specific amoxicillin dosing is essential due to differing resistance profiles of Staphylococcus aureus and Staphylococcus pseudintermedius.
- High-dose amoxicillin therapy is recommended for resistant Staphylococcus aureus infections in dogs.
- Adjusted amoxicillin dosing strategies are advised for Staphylococcus pseudintermedius infections, contributing to veterinary antimicrobial stewardship.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
08:30One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
